• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors

    View/Open
    Accepted version (15.89Kb)
    Volume
    32
    DOI
    10.1200/jco.2014.32.15_suppl.2531
    Issue
    15
    ISSN
    0732-183X
    Metadata
    Show full item record
    Authors
    Ghazaly, EA; Rizzuto, I; Gabra, H; Habib, NA; Leonard, RCF; Wasan, H; McGuigan, C; Blagden, SP
    URI
    http://meetinglibrary.asco.org/content/149421-156
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/11296
    Collections
    • Centre for Haemato-Oncology [157]
    Copyright statements
    American Society of Clinical Oncology
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.